A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Clinical evaluation of an automated, rapid mariPOC antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infection




TekijätGunell Marianne, Rantasärkkä Kaisa, Arjonen Rita, Sanden Antti, Vuorinen Tytti

KustantajaWILEY

Julkaisuvuosi2023

JournalJournal of Medical Virology

Tietokannassa oleva lehden nimiJOURNAL OF MEDICAL VIROLOGY

Lehden akronyymiJ MED VIROL

Sivujen määrä7

ISSN0146-6615

DOIhttps://doi.org/10.1002/jmv.28189

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/176814395


Tiivistelmä
A novel automated mariPOC SARS-CoV-2 antigen test was evaluated in a Health Care Center Laboratory among symptomatic and asymptomatic individuals seeking SARS-CoV-2 testing. According to the national testing strategy, reverse transcription polymerase chain reaction (RT-PCR) was used as a reference method. A total of 962 subjects were included in this study, 4.8% (46/962) of their samples were SARS-CoV-2 RT-PCR-positive, and 87% (40/46) of these were from symptomatics. Among the symptomatics, the overall sensitivity of the mariPOC SARS-CoV-2 test was 82.5% (33/40), though the sensitivity increased to 97.1% (33/34) in samples with a C-t < 30. The mariPOC SARS-CoV-2 test detected two of six PCR-positive samples among the asymptomatics, four cases that remained antigen test negative had C-t values between 28 and 36. The specificity of the mariPOC SARS-CoV-2 test was 100% (916/916). The evaluation showed that the mariPOC SARS-CoV-2 rapid antigen test is very sensitive and specific for the detection of individuals who most probably are contagious.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 15:44